Combining serum peptide signatures with international federation of gynecology and obstetrics (figo) risk score to predict the outcomes of patients with gestational trophoblastic neoplasia (gtn) after first-line chemotherapy

HIGHLIGHTS

• who: Fei Wang et al. from the Universidade do Porto, Portugal United States have published the research work: Combining serum peptide signatures with International Federation of Gynecology and Obstetrics (FIGO) risk score to predict the outcomes of patients with gestational trophoblastic neoplasia (GTN) after first-line chemotherapy, in the Journal: (JOURNAL)
• what: In present study the authors intended to discover serum peptide signatures that are closely related to the outcome of GTN patients.
• future: Other confirmatory experiments could contribute to establishing the utility of these peptides in the prognostic assessment of GTN patients . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.